Gilead Sciences
GILD
#81
Rank
A$300.08 B
Marketcap
A$241.94
Share price
-0.41%
Change (1 day)
33.07%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2023 (TTM): A$6.62

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is A-$4.49. In 2022 the company made an earnings per share (EPS) of A$5.32 a decrease over its 2021 EPS that were of A$7.18.

EPS history for Gilead Sciences from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$6.6224.39%
2022A$5.32-25.86%
2021A$7.184850%
2020A$0.14-97.64%
2019A$6.150.9%
2018A$6.0918.71%
2017A$5.13-64.88%
2016A$14.61-18.45%
2015A$17.9255.28%
2014A$11.54296.02%
2013A$2.9117.89%
2012A$2.47-6.32%
2011A$2.647.69%
2010A$2.4515.75%
2009A$2.1236.45%
2008A$1.5522.99%
2007A$1.26-233.33%
2006A-$0.95-246.63%
2005A$0.6571.15%
2004A$0.38-633.33%
2003A-$0.07067-205.41%
2002A$0.0670529.82%
2001A$0.05165-174.51%
2000A-$0.06931-1.92%
1999A-$0.0706719.18%
1998A-$0.05930-30.38%
1997A-$0.08517141.03%
1996A-$0.03534

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.69-315.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$1.10-124.52%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$5.18-215.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.75-1,095.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$23.51-623.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$3.42-176.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$8.54-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$25.12-659.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.44-132.02%๐Ÿ‡บ๐Ÿ‡ธ USA